XML 22 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
JonesTrading, ATM Agreement
Common Stock
Common Stock
JonesTrading, ATM Agreement
Additional Paid-in Capital
Additional Paid-in Capital
JonesTrading, ATM Agreement
Accumulated Deficit
Balance (in shares) at Dec. 31, 2015     38,040,891        
Balance at Dec. 31, 2015 $ (26,234)   $ 380   $ 376,528   $ (403,142)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock in direct offering, net of offering costs 37,314 $ 725 $ 35 $ 1 37,279 $ 724  
Issuance of common stock and pre-funded warrants, net of offering costs (shares)     3,478,260 64,565      
Warrant exercises 7   $ 7   0    
Issuance of common stock upon exercise of warrants (shares)     749,250        
Issuance of common stock upon exercise of stock options 3,146   $ 15   3,131    
Issuance of common stock upon exercise of stock options for cash (in shares)     1,486,167        
Stock-based compensation 13,582       13,582    
Fair value of warrants in connection with amendment to notes payable 758            
Net loss (66,745)           (66,745)
Balance (in shares) at Dec. 31, 2016     43,819,133        
Balance at Dec. 31, 2016 (37,447)   $ 438   432,002   (469,887)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock in direct offering, net of offering costs 63,657   $ 30   63,627    
Issuance of common stock and pre-funded warrants, net of offering costs (shares)     3,000,000        
Issuance of common stock upon exercise of stock options 11,769   $ 14   11,755    
Issuance of common stock upon exercise of stock options for cash (in shares)     1,392,093        
Stock-based compensation 12,688       12,688    
Net loss (53,481)           (53,481)
Balance (in shares) at Dec. 31, 2017     48,211,226        
Balance at Dec. 31, 2017 (2,814)   $ 482   520,072   (523,368)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Warrant exercises 1,424       1,424    
Issuance of common stock upon exercise of stock options $ 6,732   $ 8   6,724    
Issuance of common stock upon exercise of stock options for cash (in shares) 765,949   800,458        
Stock-based compensation $ 11,713       11,713    
Premium paid for Capped Call in connection with Convertible Notes (33,180)       (33,180)    
Fair value of warrants in connection with amendment to notes payable 55,655       55,655    
Tax benefit related to equity component of Convertible Notes (12,929)       (12,929)    
Net loss (126,757)           (126,757)
Balance (in shares) at Dec. 31, 2018     49,011,684        
Balance at Dec. 31, 2018 $ (100,156)   $ 490   $ 549,479   $ (650,125)